FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Timothy Caulfield

Research Profile

Geographic Areas

Concepts & Ideas

Procedures

Activities & Behaviors

Genes & Molecular Sequences

Genome, Human

Occupations

Anatomy

Stem Cells

Co-author Network

Publications

TOP 3
Ubaka Ogbogu; Christen Rachul; Timothy Caulfield
Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?
Kim D Raine; Timothy Caulfield; Diane Finegood; Monique Potvin Kent; Jane Landon; Tim Lobstein; Lyne Mongeau; Neil Neary; Suzie Pellerin; John C Spence
Restricting marketing to children: Consensus on policy interventions to address obesity.
Ubaka Ogbogu; Christen Rachul; Lisa Bélanger; Li Du; Timothy Caulfield
Chinese newspaper coverage of (unproven) stem cell therapies and their providers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Timothy Caulfield (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ubaka Ogbogu; Christen Rachul; Timothy Caulfield
Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?
Regenerative medicine 2013;8(3):361-9.
2013: Kim D Raine; Timothy Caulfield; Diane Finegood; Monique Potvin Kent; Jane Landon; Tim Lobstein; Lyne Mongeau; Neil Neary; Suzie Pellerin; John C Spence
Restricting marketing to children: Consensus on policy interventions to address obesity.
Journal of public health policy 2013;34(2):239-53.
2013: Ubaka Ogbogu; Christen Rachul; Lisa Bélanger; Li Du; Timothy Caulfield
Chinese newspaper coverage of (unproven) stem cell therapies and their providers.
Stem cell reviews 2013;9(2):111-8.
2013: Timothy Caulfield; Pascal Borry
Direct-to-consumer genetic testing - where should we focus the policy debate?
The Medical journal of Australia 2013;198(9):499-500.
2013: Zubin Master; Mark D Minden; Christen Rachul; Jean C Y Wang; Jaime O Claudio; Timothy Caulfield
Cancer patient perceptions on the ethical and legal issues related to biobanking.
BMC medical genomics 2013;6():8.
2012: Timothy Caulfield; Christen Rachul; Amy Zarzeczny
The evolution of policy issues in stem cell research: an international survey.
Stem cell reviews 2012;8(4):1037-42.
2012: Tania Bubela; Timothy Caulfield; Emily Culme-Seymour; Richard Gold; Judy Illes; Rosario M Isasi; Matthew D Li; Christopher Joseph McCabe; Ubaka Ogbogu; James Piret; Amir Reshef; Harold Atkins; Chris Mason
Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation.
Regenerative medicine 2012;7(6):735-40.
2012: Timothy Caulfield; Amy McGuire
Athletes' use of unproven stem cell therapies: adding to inappropriate media hype?
Molecular therapy : the journal of the American Society of Gene Therapy 2012;20(9):1656-8.
2012: Zubin Master; Blake Murdoch; Erin Nelson; Timothy Caulfield
Biobanks, consent and claims of consensus.
Nature methods 2012;9(9):885-8.
2012: John C Spence; Nancy Spencer-Cavaliere; Christopher J Sprysak; Nicholas L Holt; Timothy Caulfield
Non-refundable tax credits are an inequitable policy instrument for promoting physical activity among Canadian children.
Canadian journal of public health. Revue canadienne de santé publique 2012;103(3):175-7.
2012: Timothy Caulfield; Amy Zarzeczny
Stem cell tourism and Canadian family physicians.
Canadian family physician Médecin de famille canadien 2012;58(4):365-8, e182-5.
2012: Amy Zarzeczny; Timothy Caulfield
Legal liability and research ethics boards: the case of neuroimaging and incidental findings.
International journal of law and psychiatry 2012;35(2):137-45.
2012: Timothy Caulfield
Should we call it fraud?
The Hastings Center report 2012;42(1):49.
2012: Timothy Caulfield; C Condit
Science and the sources of hype.
Public health genomics 2012;15(3-4):209-17.
2012: Timothy Caulfield; Shawn He Harmon; Yann Joly
Open science versus commercialization: a modern research conflict?
Genome medicine 2012;4(2):17.
2012: Timothy Caulfield; Amy L McGuire
Direct-to-consumer genetic testing: perceptions, problems, and policy responses.
Annual review of medicine 2012;63():23-33.
2011: Timothy Caulfield
Reflections on the gene patent war: the myriad battle, Sputnik and beyond.
Clinical chemistry 2011;57(7):977-9.
2011: Timothy Caulfield
Direct-to-consumer testing: if consumers are not anxious, why are policymakers?
Human genetics 2011;130(1):23-5.
2011: Christen M Rachul; Nola M Ries; Timothy Caulfield
Canadian newspaper coverage of the A/H1N1 vaccine program.
Canadian journal of public health. Revue canadienne de santé publique 2011;102(3):200-3.
2011: Timothy Caulfield; C Rachul
Science spin: iPS cell research in the news.
Clinical pharmacology and therapeutics 2011;89(5):644-6.
2011: Christen Rachul; CA Ouellette; Timothy Caulfield
Tracing the use and source of racial terminology in representations of genetic research.
Genetics in medicine : official journal of the American College of Medical Genetics 2011;13(4):314-9.
2011: Nola M Ries; Christen Rachul; Timothy Caulfield
Newspaper reporting on legislative and policy interventions to address obesity: United States, Canada, and the United Kingdom.
Journal of public health policy 2011;32(1):73-90.
2011: Blake Murdoch; Robyn Hyde-Lay; Timothy Caulfield
Commentary: An examination of the public justifications for the expansion of Canadian naturopaths' scope of practice.
Health law journal 2011;19():215-36.
2011: Timothy Caulfield; Christen Rachul
Supported by science?: what canadian naturopaths advertise to the public.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2011;7():14.
2011: Tania Stafinski; Deborah Marshall; Devidas Menon; Timothy Caulfield
Societal values in the allocation of healthcare resources: is it all about the health gain?
The patient 2011;4(4):207-25.
2010: Amy Zarzeczny; Christen Rachul; Matthew Nisbet; Timothy Caulfield
Stem cell clinics in the news.
Nature biotechnology 2010;28(12):1243-6.
2010: Yann Joly; Bartha M Knoppers; Timothy Caulfield; Eef Harmsen; Tomi Pastinen
The commercialization of genomic research in Canada.
Healthcare policy = Politiques de santé 2010;6(2):24-32.
2010: Tania M Bubela; Timothy Caulfield
Role and reality: technology transfer at Canadian universities.
Trends in biotechnology 2010;28(9):447-51.
2010: Timothy Caulfield; Amy Zarzeczny
Popular culture representations of science: views from the Canadian stem cell research community.
Stem cell reviews 2010;6(3):337-9.
2010: Amy Zarzeczny; Timothy Caulfield
Stem cell tourism and doctors' duties to minors--a view from Canada.
The American journal of bioethics : AJOB 2010;10(5):3-15.
2010: Timothy Caulfield; Nola M Ries; P N Ray; C Shuman; B Wilson
Direct-to-consumer genetic testing: good, bad or benign?
Clinical genetics 2010;77(2):101-5.
2010: Timothy Caulfield
Stem cell research and economic promises.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2010;38(2):303-13.
2010: Nola M Ries; Jane LeGrandeur; Timothy Caulfield
Handling ethical, legal and social issues in birth cohort studies involving genetic research: responses from studies in six countries.
BMC medical ethics 2010;11():4.
2010: Timothy Caulfield; Christopher Scott; Insoo Hyun; Robin Lovell-Badge; Kazuto Kato; Amy Zarzeczny
Stem cell research policy and iPS cells.
Nature methods 2010;7(1):28-33.
2010: Nola M Ries; R Hyde-Lay; Timothy Caulfield
Willingness to pay for genetic testing: a study of attitudes in a Canadian population.
Public health genomics 2010;13(5):292-300.
2009: Amy Zarzeczny; Christopher Scott; Insoo Hyun; Jami Bennett; Jennifer Chandler; Sophie Chargé; Heather Heine; Rosario M Isasi; Kazuto Kato; Robin Lovell-Badge; Kelly McNagny; Duanqing Pei; Janet Rossant; Azim Surani; Patrick L Taylor; Ubaka Ogbogu; Timothy Caulfield
iPS cells: mapping the policy issues.
Cell 2009;139(6):1032-7.
2009: Amy Zarzeczny; Timothy Caulfield
Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo.
Stem cell reviews 2009;5(2):96-101.
2009: Timothy Caulfield; Amy Zarzeczny; Jennifer McCormick; Tania Bubela; Christine Critchley; Edna Einsiedel; Jacques Galipeau; Shawn Harmon; Michael Huynh; Insoo Hyun; Judy Illes; Rosario M Isasi; Yann Joly; Graeme Laurie; Geoff Lomax; Holly Longstaff; Michael McDonald; Charles Murdoch; Ubaka Ogbogu; Jason Owen-Smith; Shaun Pattinson; Shainur Premji; Barbara von Tigerstrom; David E Winickoff
The stem cell research environment: a patchwork of patchworks.
Stem cell reviews 2009;5(2):82-8.
2009: Tania Bubela; Matthew C Nisbet; Rick Borchelt; Fern Brunger; Cristine Critchley; Edna Einsiedel; Gail Geller; Anil Gupta; Jürgen Hampel; Robyn Hyde-Lay; Eric W Jandciu; S Ashley Jones; Pam Kolopack; Summer Lane; Tim Lougheed; Brigitte Nerlich; Ubaka Ogbogu; Kathleen O'Riordan; CA Ouellette; Mike Spear; Stephen Strauss; Thushaanthini Thavaratnam; Lisa Willemse; Timothy Caulfield
Science communication reconsidered.
Nature biotechnology 2009;27(6):514-8.
2009: Peter J Rugg-Gunn; Ubaka Ogbogu; Janet Rossant; Timothy Caulfield
The challenge of regulating rapidly changing science: stem cell legislation in Canada.
Cell stem cell 2009;4(4):285-8.
2009: Timothy Caulfield
Nutrigenomics patents and commercialization: old wine in a new bottle?
Omics : a journal of integrative biology 2009;13(1):63-7.
2009: Timothy Caulfield
Direct-to-consumer genetics and health policy: a worst-case scenario?
The American journal of bioethics : AJOB 2009;9(6-7):48-50.
2009: Alethea Adair; Robyn Hyde-Lay; Edna Einsiedel; Timothy Caulfield
Technology assessment and resource allocation for predictive genetic testing: a study of the perspectives of Canadian genetic health care providers.
BMC medical ethics 2009;10():6.
2009: Timothy Caulfield; Stephanie M Fullerton; Sarah E Ali-Khan; Laura Arbour; Esteban G Burchard; Richard S Cooper; Billie-Jo Hardy; Simrat Harry; Robyn Hyde-Lay; Jonathan Kahn; Rick Kittles; Barbara A Koenig; Sandra Sj Lee; Michael Malinowski; Vardit Ravitsky; Pamela Sankar; Stephen W Scherer; Béatrice Séguin; Darren Shickle; Guilherme Suarez-Kurtz; Abdallah S Daar
Race and ancestry in biomedical research: exploring the challenges.
Genome medicine 2009;1(1):8.
2009: Cj Murdoch; Timothy Caulfield
Commercialization, patenting and genomics: researcher perspectives.
Genome medicine 2009;1(2):22.
2008: Darren Lau; Ubaka Ogbogu; Benjamin Taylor; Tania Stafinski; Devidas Menon; Timothy Caulfield
Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine.
Cell stem cell 2008;3(6):591-4.
2008: Timothy Caulfield; Ubaka Ogbogu
Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
Accountability in research 2008;15(4):303-20.
2008: Timothy Caulfield; Ubaka Ogbogu; Charles Murdoch; Edna Einsiedel
Patents, commercialization and the Canadian stem cell research community.
Regenerative medicine 2008;3(4):483-96.
2008: Timothy Caulfield; Amy L McGuire; Mildred Cho; Janet A Buchanan; Michael M Burgess; Ursula Danilczyk; Christina Diaz; Kelly Fryer-Edwards; Shane K Green; Marc A Hodosh; Eric T Juengst; Jane Kaye; Laurence Kedes; Bartha Maria Knoppers; Trudo Lemmens; Eric M Meslin; Juli Murphy; Robert L Nussbaum; Margaret Otlowski; Daryl Pullman; Peter N Ray; Jeremy Sugarman; Michael Timmons
Research ethics recommendations for whole-genome research: consensus statement.
PLoS biology 2008;6(3):e73.
2008: Tania Bubela; Heather Boon; Timothy Caulfield
Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals.
BMC medicine 2008;6():35.
2008: Timothy Caulfield; Simrat Harry
Popular representations of race: the news coverage of BiDil.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2008;36(3):485-90.
2007: Timothy Caulfield; Tania Bubela; C J Murdoch
Myriad and the mass media: the covering of a gene patent controversy.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(12):850-5.
2007: Erin Nelson; Ubaka Ogbogu; Timothy Caulfield
An investigation of embryo donation, informed consent, and research oversight in Canadian human embryonic stem cell research.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 2007;29(12):997-1002.
2007: Timothy Caulfield; Ubaka Ogbogu; Erin Nelson; Edna Einsiedel; Bartha Maria Knoppers; Michael McDonald; Fern Brunger; Robin Downey; Kanchana Fernando; Jacques Galipeau; Rose Geransar; Glenn Griener; Glenn Grenier; Insoo Hyun; Rosario M Isasi; Melanie Kardel; Lori Knowles; Terrence Kucic; Salla Lotjonen; Drew Lyall; David Magnus; Debra J H Mathews; Matthew Nisbet; Jeff Nisker; Guillaume Pare; Shaun Pattinson; Daryl Pullman; Michael Rudnicki; Bryn Williams-Jones; Susan Zimmerman
Stem cell research ethics: consensus statement on emerging issues.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 2007;29(10):843-8.
2007: Timothy Caulfield
Obesity, legal duties, and the family physician.
Canadian family physician Médecin de famille canadien 2007;53(7):1129-30, 1133-5.
2007: Timothy Caulfield; Ubaka Ogbogu; Rosario M Isasi
Informed consent in embryonic stem cell research: are we following basic principles?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2007;176(12):1722-5.
2007: Tania Bubela; M Koper; Heather Boon; Timothy Caulfield
Media portrayal of herbal remedies versus pharmaceutical clinical trials: impacts on decision.
Medicine and law 2007;26(2):363-73.
2007: Timothy Caulfield; Tania Bubela
Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate.
The American journal of bioethics : AJOB 2007;7(2):51-61.
2006: Timothy Caulfield; Edna Einsiedel; Jon F Merz; Dianne Nicol
Trust, patents and public perceptions: the governance of controversial biotechnology research.
Nature biotechnology 2006;24(11):1352-4.
2006: Timothy Caulfield
Introduction: genetic diversity and science communication.
Clinical genetics 2006;70(5):424-6.
2006: Timothy Caulfield; Robert Cook-Deegan; F Scott Kieff; John P Walsh
Evidence and anecdotes: an analysis of human gene patenting controversies.
Nature biotechnology 2006;24(9):1091-4.
2006: Timothy Caulfield; Barbara von Tigerstrom
Gene patents, health care policy and licensing schemes.
Trends in biotechnology 2006;24(6):251-4.
2006: Suzanne B DeBow; Tania Bubela; Timothy Caulfield
Stem cells, politics and the progress paradigm.
Health law review 2006;15(1):50-2.
2006: Megan Koper; Tania Bubela; Timothy Caulfield; Heather Boon
Media portrayal of conflicts of interest in herbal remedy clinical trials.
Health law review 2006;15(1):9-11.
2006: Timothy Caulfield; Roger Brownsword
Human dignity: a guide to policy making in the biotechnology era?
Nature reviews. Genetics 2006;7(1):72-6.
2005: Timothy Caulfield; Audrey Chapman
Human dignity as a criterion for science policy.
PLoS medicine 2005;2(8):e244.
2005: Nola M Ries; Timothy Caulfield
Legal foundations for a national public health agency in Canada.
Canadian journal of public health. Revue canadienne de santé publique 2005;96(4):281-3.
2005: Timothy Caulfield
Commentary: an independent voice?: conflicts of interest and research on ethical, legal and social issues.
Health law review 2005;13(2-3):114-6.
2005: Timothy Caulfield
Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
Health law review 2005;13(2-3):58-61.
2005: Timothy Caulfield
Policy conflicts: gene patents and health care in Canada.
Community genetics 2005;8(4):223-7.
2005: Timothy Caulfield; Suzanne B DeBow
A systematic review of how homeopathy is represented in conventional and CAM peer reviewed journals.
BMC complementary and alternative medicine 2005;5():12.
2004: Shaun Pattinson; Timothy Caulfield
Variations and voids: the regulation of human cloning around the world.
BMC medical ethics 2004;5():E9.
2004: Timothy Caulfield
The commercialisation of medical and scientific reporting.
PLoS medicine 2004;1(3):e38.
2004: Timothy Caulfield; L Knowles; E M Meslin
Law and policy in the era of reproductive genetics.
Journal of medical ethics 2004;30(4):414-7.
2004: Timothy Caulfield
Scientific freedom and research cloning: can a ban be justified?
Lancet 2004;364(9429):124-6.
2004: Timothy Caulfield
Biotechnology and the popular press: hype and the selling of science.
Trends in biotechnology 2004;22(7):337-9.
2004: Tania Bubela; Timothy Caulfield
Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;170(9):1399-407.
2004: Barbara Billingsley; Timothy Caulfield
The regulation of science and the Charter of Rights: would a ban on non-reproductive human cloning unjustifiably violate freedom of expression?
Queen's law journal 2004;29(2):647-79.
2004: Timothy Caulfield; Trudo Lemmens; Douglas Kinsella; Michael McDonald
Research ethics and the role of the professional bodies: a view from Canada.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2004;32(2):365-8.
2004: Timothy Caulfield
Tissue banking, patient rights, and confidentiality: tensions in law and policy.
Medicine and law 2004;23(1):39-49.
2003: Timothy Caulfield
Human cloning laws, human dignity and the poverty of the policy making dialogue.
BMC medical ethics 2003;4():E3.
2003: Timothy Caulfield
From human genes to stem cells: new challenges for patent law?
Trends in biotechnology 2003;21(3):101-3.
2003: Timothy Caulfield
Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research.
Saskatchewan law review 2003;66(2):629-45.
2003: Timothy Caulfield; Bartha Maria Knoppers; Richard Gold; Lorraine Sheremeta; PJ Bridge
Genetic technologies, health care policy and the patent bargain.
Clinical genetics 2003;63(1):15-8.
2002: Timothy Caulfield; Tim Outerbridge
DNA databanks, public opinion and the law.
Clinical and investigative medicine. Médecine clinique et experimentale 2002;25(6):252-6.
2002: Timothy Caulfield
Politics, prohibitions and the lost public perspective: a comment on Bill C-56: the Assisted Human Reproduction Act.
Alberta law review 2002;40(2):451-63.
2002: Richard Gold; Timothy Caulfield; Peter N Ray
Gene patents and the standard of care.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(3):256-7.
2002: Richard Gold; Timothy Caulfield
The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology.
Lancet 2002;359(9325):2268-70.
2002: Timothy Caulfield; Kerry Siminoski
Physicians' liability and drug formulary restrictions.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(4):458-60.
2002: Timothy Caulfield
Bill C-13 The Assisted Human Reproduction Act: examining the arguments against a regulatory approach.
Health law review 2002;11(1):20-5.
2002: P Saradhi Puttagunta; Timothy Caulfield; Glenn Griener
Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
Health law review 2002;10(2):30-2.
2002: Timothy Caulfield; Glenn Griener
Conflicts of interest in clinical research: addressing the issue of physician remuneration.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2002;30(2):305-8.
2001: Timothy Caulfield
Clones, controversy, and criminal law: a comment on the proposal for legislation governing assisted human reproduction.
Alberta law review 2001;39(2):335-45.
2001: Timothy Caulfield
Cloning and genetic determinism--a call for consistency.
Nature biotechnology 2001;19(5):403.
2001: Timothy Caulfield
The informed gatekeeper?: a commentary on genetic tests, marketing pressure and the role of primary care physicians.
Health law review 2001;9(3):14-8.
2001: Timothy Caulfield; G B Robertson
Xenotransplantation: consent, public health and charter issues.
Medical law international 2001;5(2):81-99.
2001: Timothy Caulfield; D Wertz
Creating needs? A review of survey data and concerns relevant to the commercialization of genetic testing.
Community genetics 2001;4(2):68-76.
2001: Timothy Caulfield; C Feasby
Potions, promises and paradoxes: complementary medicine and alternative medicine and malpractice law in Canada.
Health law journal 2001;9():183-203.
2000: Timothy Caulfield; Richard Gold; M K Cho
Patenting human genetic material: refocusing the debate.
Nature reviews. Genetics 2000;1(3):227-31.
2000: Timothy Caulfield
Underwhelmed: hyperbole, regulatory policy, and the genetic revolution.
McGill law journal. Revue de droit de McGill 2000;45(2):437-60.
2000: Timothy Caulfield; Richard Gold
Genetic testing, ethical concerns, and the role of patent law.
Clinical genetics 2000;57(5):370-5.
2000: Timothy Caulfield; Richard Gold
Whistling in the wind: patents on genetic research are a reality. It's time to reframe the debate.
Forum for applied research and public policy 2000;15(1):75-9.
2000: B von Tigerstrom; M Deschênes; Bartha Maria Knoppers; Timothy Caulfield
Legal regulation of cancer surveillance: Canadian and international perspectives.
Health law journal 2000;8():1-94, i-xxxiv.
1999: PS Florencio; Timothy Caulfield
Xenotransplantation and public health: identifying the legal issues.
Canadian journal of public health. Revue canadienne de santé publique 1999;90(4):282-4.
1999: Timothy Caulfield; M Hirtle
Regulating the genetic revolution.
Molecular medicine today 1999;5(5):198-200.
1998: Timothy Caulfield; E Nelson
Winnipeg Child and Family Services v. D.F.G.: a commentary on the law, reproductive autonomy and the allure of technopolicy.
Alberta law review 1998;36(3):799-809.
1998: Timothy Caulfield
The commercialization of human genetics: profits and problems.
Molecular medicine today 1998;4(4):148-50.
1998: Timothy Caulfield; Bartha Maria Knoppers
Genetic testing, legal capacity and adolescents.
Health law journal 1998;6 Spec No():115-29.
1998: E Nelson; Timothy Caulfield
You can't get there from here: a case comment on Arndt v. Smith.
University of British Columbia law review. University of British Columbia 1998;32(2):353-64.
1997: Timothy Caulfield; J Dossetor; Lynn K Boshkov; J Hannon; D Sawyer; G Robertson
Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: integrating science, legal duties and ethical mandates.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1997;157(10):1389-92.
1997: Timothy Caulfield; M Hirtle; S Le Bris
Regulating NRGTs (new reproductive and genetic technologies): is criminalization the solution for Canada?
Health law in Canada 1997;18(1):3-14.
1996: Timothy Caulfield
Wishful thinking: defining "medically necessary" in Canada.
Health law journal 1996;4():63-85.
1995: Timothy Caulfield
Practically confidential. Legal and ethical dilemmas in practice.
Canadian family physician Médecin de famille canadien 1995;41():2025-7.
1995: Timothy Caulfield
The practice of human genetics: emerging areas of consensus?
Health law journal 1995;3():307-20.
1995: Timothy Caulfield
The allocation of genetic services: economics, expectations, ethics and the law.
Health law journal 1995;3():213-34.